Article
HCV clearance and treatment outcome in genotype 1 HCV-monoinfected, HIV-coinfected and liver transplanted patients on peg-IFN-alpha-2b/ribavirin.
Journal of hepatology - 1 Nov 2005
Moreno Ana, Bárcena Rafael, García-Garzón Silvia, Muriel Alfonso, Quereda Carmen, Moreno Leonor, Mateos María L, Fortún Jesús, Martín-Dávila Pilar, García Miguel, Blesa Carlos, Otón Elena, Moreno Alberto, Moreno Santiago
Abstract excerpt
BACKGROUND/AIMS: Differences in HCV-RNA clearance during therapy might explain the lower efficacy of peg-IFN/RBV in HIV/HCV-coinfection. There are limited data on HCV-RNA clearance and treatment outcomes in liver transplanted (LT) patients. METHODS: To assess the rates of SVR and baseline predictors of failure after 48 weeks of weight-adjusted peg-IFN-alpha-2b/RBV in 120 patients with HCV genotype 1: 61...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
